Detailed Information on Publication Record
2017
Intravenous thrombolysis for ischemic stroke in the golden hour: propensity-matched analysis from the SITS-EAST registry
TSIVGOULIS, G., A.H. KATSANOS, P. KADLECOVA, A. CZLONKOWSKA, A. KOBAYASHI et. al.Basic information
Original name
Intravenous thrombolysis for ischemic stroke in the golden hour: propensity-matched analysis from the SITS-EAST registry
Authors
TSIVGOULIS, G. (300 Greece), A.H. KATSANOS (300 Greece), P. KADLECOVA (203 Czech Republic), A. CZLONKOWSKA (616 Poland), A. KOBAYASHI (616 Poland), M. BROZMAN (703 Slovakia), V. SVIGELJ (705 Slovenia), L. CSIBA (348 Hungary), K. FEKETE (233 Estonia), J. KORV (233 Estonia), V. DEMARIN (191 Croatia), A. VILIONSKIS (440 Lithuania), D. JATUZIS (440 Lithuania), Y. KRESPI (792 Turkey), C. LIANTINIOTI (300 Greece), S. GIANNOPOULOS (300 Greece) and Robert MIKULÍK (203 Czech Republic, guarantor, belonging to the institution)
Edition
European Journal of Neurology, HEIDELBERG, SPRINGER HEIDELBERG, 2017, 0340-5354
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30210 Clinical neurology
Country of publisher
Germany
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 3.783
RIV identification code
RIV/00216224:14110/17:00100262
Organization unit
Faculty of Medicine
UT WoS
000400617200011
Keywords in English
Intravenous thrombolysis; Acute ischemic stroke; Golden hour; Onset-to-treatment time; Mobile stroke unit
Tags
Tags
International impact, Reviewed
Změněno: 26/4/2018 10:38, Soňa Böhmová
Abstract
V originále
As there are scarce data regarding the outcomes of acute ischemic stroke (AIS) patients treated with intravenous thrombolysis (IVT) within 60 min from symptom onset ("golden hour"), we sought to compare outcomes between AIS patients treated within [GH(+)] and outside [GH(-)] the "golden hour" by analyzing propensity score matched data from the SITS-EAST registry. Clinical recovery (CR) at 2 and 24 h was defined as a reduction of ae10 points on NIHSS-score or a total NIHSS-score of ae3 at 2 and 24 h, respectively. A relative reduction in NIHSS-score of ae40% at 2 h was considered predictive of complete recanalization (CREC). Symptomatic intracranial hemorrhage (sICH) was defined using SITS-MOST criteria. Favorable functional outcome (FFO) was defined as a mRS-score of 0-1 at 3 months. Out of 19,077 IVT-treated AIS patients, 71 GH(+) patients were matched to 6882 GH(-) patients, with no differences in baseline characteristics (p > 0.1). GH(+) had higher rates of CR at 2 (31.0 vs. 12.4%; p < 0.001) and 24 h (41 vs. 27%; p = 0.010), CREC at 2 h (39 vs. 21%; p < 0.001) and FFO (46.5 vs. 34.0%; p = 0.028) at 3 months. The rates of sICH and 3-month mortality did not differ (p > 0.2) between the two groups. GH(+) was associated with 2-h CR (OR: 5.34; 95% CI 2.53-11.03) and CREC (OR: 2.38; 95% CI 1.38-4.09), 24-h CR (OR: 1.88; 95% CI 1.08-3.26) and 3-month FFO (OR: 2.02; 95% CI 1.15-3.54) in multivariable logistic regression models adjusting for potential confounders. In conclusion, AIS treated with IVT within the GH seems to have substantially higher odds of early neurological recovery, CREC, 3-month FFO and functional improvement.